Explore small cap ideas before they hit the headlines.
Explore small cap ideas before they hit the headlines.
Did anyone attend today's shareholder meeting? Do we know the results?
My vote is - NO
Is this from an article? Can you share a link to it?
Deja Vu, oh boy, it's 1999 all over again: "Shares of Continucare, another Miami company Frost vice-chairs, have traded below $1 since March after peaking above $10 three years ago. Continucare, which provides a variety of outpatient health services and manages health clubs for Bally Total Fitness, lost $15 million in fiscal 1998 and $31 million three quarters into fiscal 1999. In June, it missed an interest payment on $45 million in debt. (Continucare Chairman and CEO Charles Fernandez sits on Ivax's board.)"
https://www.floridatrend.com/print/article/13359
Charles M. Fernandez has resigned as president and CEO of Continucare Corp. (AMEX: CNU)
https://www.bizjournals.com/southflorida/stories/1999/11/01/daily21.html
We would know if that was the case—it would have to be disclosed.
I hope he’s considering averaging down and buying more stock at these levels. If he liked it at over $2 a share, he should really love it at under a dollar.
I’d be curious to know how Phil Frost feels about his $6 million investment in NextPlat—he must be frustrated. Does anyone have his contact information? I’d really like to connect with him and have a conversation.
We need more details for this statement: "Total pharmacy prescription and 340B contract revenues were approximately $11.5 million and $12.4 million for the three months ended September 30, 2024 and 2023, respectively, a decrease of approximately $0.8 million. The decrease was primarily due to a decrease in pharmacy prescription reimbursement rates. The pharmacy filled approximately 128,000 and 122,000 prescriptions for the three months ended September 30, 2024 and 2023, respectively."
While the pharmacies filled 6,000 more prescriptions, revenue went down 800k. We would have to better understand where this decrease in reimbursements is coming from.
This is from the company's Q-2:
The Company performed a goodwill impairment test during the three months ended June 30, 2024 and it was determined that the carrying amount of goodwill at June 30, 2024 exceeded its fair value resulting in the Company recording a non-cash impairment charge of approximately $0.7 million during the period, recorded to the Healthcare Operations reporting segment. As of June 30, 2024, there was no remaining goodwill as it relates to the Healthcare Operations reporting segment.
And this is Q-3:
The Company performed a long-lived assets impairment test as it relates to the Healthcare Operations reporting segment during the three months ended September 30, 2024 and it was determined that the carrying amount of the asset group at September 30, 2024 exceeded its fair value resulting in the Company recording a non-cash impairment charge to certain long-lived assets, primarily intangible assets, of approximately $3.7 million during the period. Refer to Note 11. Goodwill and Intangible Assets to our quarterly financials for additional details on the impairment charge, valuation methodologies, inputs used in the fair value measurements, and the changes in intangible assets for the period.
As a shareholder, I'm honestly confused by the valuation report indicating ongoing cash burn and minimal 3% growth. Why would NXPL acquire the company with this crapy trend? Are they planning to buy it just to maintain cash burn with almost no growth? How is the NXPL board voting to issue a ton of stock to buy a company that will be adding to their losses? Just thinking... asking obvious questions.
In my opinion, friendships often change when legal risks arise. None of them probably want to face litigation, no matter how close their friendships are.
If the valuation comes back to our advantage, then the RXMD Board will have to get a wake-up call! 😎 And will serve as a wake-up call for all shareholders to unite our efforts and urge the Board to reconsider their decision. Their job is to representing our best interests and fulfill their fiduciary responsibility to protect the value of RXMD. That is my thinking.
Let's take it one step at a time. First, let's await the valuation report to see what it reveals. I believe we should have it next week.
First, execute a wipeout RS and then take the company private. Cha Ching! Smart way to get your hands on over 20 million in cash and a huge commercial building. Just a thought.
I'm still not convinced that Fernandez and Baretto will be allowed to vote their shares. It might be a conflict of interest. Let's see what happens. Shareholders might end up with the majority.
LOL. It doesn't work that way. You can't take that out. The company has raised $7 million from NXPL and generated another $1 million in cash from operations. It did so so that it uplists to Nasdaq and executes on growth through acquisitions. There is no hocus pocus.
Did anyone see the description of the benefits associated with this merger in S-4? Why the RXMD Board agreed to eliminate a publicly traded healthcare company with zero debt, $8 million in cash, and double-digit growth? How will it benefit the RXMD shareholders? What is the precise vision for the combined entity?
it should be out shortly.
I suggest waiting until the independent valuation comes out before voting your shares.
waiting for the valuation report before I post my vote.
Glickman is compensated by NXPL to communicate specific messages as directed by NXPL.
Hmmm. How is the Board of Directors of RXMD allowing it to be acquired by a company trading on NASDAQ below $1?
We can't be the lambs. Time to stand up for ourselves!
A NASDAQ stock at $1 is a major red flag for a reverse split, which often ends up destroying shareholder value.
Chucky has to go!
Is the Board of RXMD still moving forward with this deal? NextPlat Corp (NXPL) $1.0001 reverse stock split post-merger pending.....
Good evening to all!